Peptide questions · LL-37
LL-37 side effects: what studies and users report
Reviewed Evidence: EmergingPublished by PepVault
The side effects most commonly reported for LL-37 are injection site pain, redness and mild systemic inflammation; the library’s evidence on it includes controlled trials in people.
The library holds no separate safety note for LL-37.
What is commonly reported with LL-37
- Injection site pain
- Redness
- Mild systemic inflammation
Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.
| Effect | Also listed for (of 18) |
|---|---|
| Injection site pain | None: listed for LL-37 alone |
| Redness | None: listed for LL-37 alone |
| Mild systemic inflammation | None: listed for LL-37 alone |

Which LL-37 side effects the healing & recovery group shares
Across the 19 healing & recovery compounds in the library, the effects listed most often are headache (7 of 19), injection site reaction (7 of 19), nausea (rare) (7 of 19) and fatigue (6 of 19). None of LL-37’s 3 listed effects appears for another healing & recovery compound: injection site pain, redness and mild systemic inflammation are its own in the library.
Where the LL-37 reports come from
The library rates the evidence on LL-37 as emerging: mostly preclinical, with limited human data.
Of the library’s 5 research notes on LL-37, 5 rest on community reports.
Our 6 study pages on LL-37: 3 randomized trials, 1 observational study, 1 cell study (human and murine macrophages) and 1 cell study (normal human keratinocytes).
So LL-37 has controlled trials in people to set its listed effects against.
What our LL-37 study pages report on safety
LL-37 taken by mouth shortened time to negative COVID-19 RNA test
Randomized trial, human, 2023: No severe side effects were seen during the hospital stay or follow-up. It measured how fast virus RNA cleared and safety, not other outcomes such as symptoms.
LL-37: no healing gain over placebo for venous leg ulcers overall
Randomized trial, human, 2021: Both strengths were well tolerated and safe.
Questions people ask
What are the side effects of LL-37?
The side effects most commonly reported for LL-37 are injection site pain, redness and mild systemic inflammation; the library’s evidence on it includes controlled trials in people.
Do LL-37’s side effects come from human studies?
The library rates the evidence on LL-37 as emerging, and the library’s evidence on it includes controlled trials in people.
Which LL-37 side effects are its own?
Among the healing & recovery compounds, the library lists injection site pain, redness and mild systemic inflammation for LL-37 alone.